Gurugram-based pesticide and crop protection manufacturer Mahamaya Lifesciences is set to enter the public markets next week. The company has announced its initial public offering (IPO), aiming to raise capital to scale operations and expand manufacturing capacity amid rising demand from domestic and multinational agrochemical players.
The IPO opens for subscription on 11 November and closes on 13 November, with a price band of ₹108–₹114 per share. The issue size is ₹70.4 crore, comprising:
The anchor book for institutional buyers will open on November 10, allotment is scheduled for November 14, and the stock is expected to list on the BSE SME platform on November 18.
Proceeds from the fresh issue will be deployed as follows:
Founded in 2002, Mahamaya Lifesciences manufactures pesticide formulations and bulk products used by leading Indian agrochemical firms and multinational corporations. The company competes with listed peers such as Nova Agritech and Bhagiradha Chemicals & Industries.
Read More: IPO Alert: Gaja Capital Gets SEBI Approval to Raise Funds!
The upcoming IPO marks the next phase of Mahamaya Lifesciences’ expansion plans, with proceeds directed towards capacity enhancement, new manufacturing capabilities and strengthening of working capital.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 5, 2025, 10:21 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN